We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Orlistat

Orlistat is a medication used to manage obesity. It works by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. By inhibiting this enzyme, Orlistat reduces the absorption of dietary fat.Here are some key medical uses of Orlistat: Weight Loss,Improvement in Insulin Sensitivity

Synchemia specializes in supply of Orlistat impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Orlistat is a medication used to treat obesity and ensuring the purity and quality of its impurities is crucial for pharmaceutical manufacturing and regulatory compliance. If you have any specific questions about Orlistat impurities or related topics, feel free to ask!

download image Download catalogue

Pharmaceutical Reference Standards

Orlistat
Orlistat
CAT No SRC-O15031
CAS No 96829-58-2
Mol.F. C29H53NO5
Mol.Wt. 495.7
INV STATUS IN STOCK
Orlistat Related Compound A
Orlistat  Related Compound A
CAT No SRC-O15032
CAS No 104872-06-2
Mol.F. C22H42O3
Mol.Wt. 354.6
INV STATUS IN STOCK
Orlistat Related Compound B
Orlistat  Related Compound B
CAT No SRC-O15033
CAS No 19740-72-8
Mol.F. C8H16N2O4
Mol.Wt. 204.2
INV STATUS IN STOCK
Orlistat Related Compound C
Orlistat  Related Compound C
CAT No SRC-O15034
CAS No 791-28-6
Mol.F. C18H15OP
Mol.Wt. 278.3
INV STATUS IN STOCK
Orlistat Related Compound D
Orlistat  Related Compound D
CAT No SRC-O15035
CAS No 130793-27-0
Mol.F. C29H53NO5
Mol.Wt. 495.7
INV STATUS IN STOCK
Orlistat Formyl Impurity
Orlistat Formyl Impurity
CAT No SRC-O15036
CAS No 6113-61-7
Mol.F. C7H13NO3
Mol.Wt. 159.2
INV STATUS IN STOCK
(R,S,S,S)-Orlistat
(R,S,S,S)-Orlistat
CAT No SRC-O15037
CAS No 104872-28-8
Mol.F. C29H53NO5
Mol.Wt. 495.8
INV STATUS CUSTOM SYNTHESIS
Orlistat Open Ring Epimer
Orlistat Open Ring Epimer
CAT No SRC-O15038
CAS No 130793-28-1
Mol.F. C29H55NO6
Mol.Wt. 513.8
INV STATUS IN STOCK
Orlistat Open Ring Impurity
Orlistat Open Ring Impurity
CAT No SRC-O15039
CAS No 130676-66-3
Mol.F. C29H55NO6
Mol.Wt. 513.8
INV STATUS IN STOCK
Orlistat Henicosenyl leucinate Impurity
Orlistat Henicosenyl leucinate Impurity
CAT No SRC-O15040
CAS No 130676-63-0
Mol.F. C28H53NO3
Mol.Wt. 451.7
INV STATUS IN STOCK
black arrow Previous 12 Next black arrow

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.